Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the ...
News Medical5h
GLP-1 and SGLT2 inhibitors show promise in preventing recurrent stroke and heart attack
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
protothema.gr9h
Obesity: 15 new drugs that are changing the world
They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...
MedPage Today19h
ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs
The estimated change in Impact of Weight on Quality of Life (IWQOL)-Lite-Clinical Trials version ... Risk in Teens ...